-
Pretty in pink: Dallas World Cup venue chasing perfect pitch
-
Wordle heads to primetime as media seek puzzle reinvention
-
Eurovision: the grand final running order
-
McIlroy, back in PGA hunt, blames bad setup for lead logjam
-
Kubo vows to lead Japan at World Cup with Mitoma out
-
McNealy and Smalley share PGA lead at difficult Aronimink
-
Drake drops three albums at once
-
Boeing confirms China commitment to buy 200 aircraft
-
Knicks forward Anunoby trains as NBA Eastern Conference finals loom
-
American McNealy grabs PGA lead at difficult Aronimink
-
Substitute 'keeper sends Saint-Etienne into promotion play-off
-
Sinner's bid to reach Italian Open final held up by Roman rain
-
Aston Villa humble Liverpool to secure Champions League qualification
-
US says Iran-backed militia commander planned Jewish site attacks
-
Bolivia unrest continues despite government deal with miners
-
Scheffler slams 'absurd' PGA pin locations
-
New deadly Ebola outbreak hits DR Congo, 1 dead in Uganda
-
Democrats accuse Trump of stock trade corruption
-
'Beyond the Oscar': Travolta gets surprise Cannes prize
-
Israel, Lebanon say extending ceasefire despite new strikes
-
Potgieter grabs early PGA lead at difficult Aronimink
-
Prosecutors seek death penalty for US man charged with killing Israeli embassy staffers
-
Judge declares mistrial in Weinstein sex assault case
-
Canada takes key step towards new oil pipeline
-
Iranian filmmaker Farhadi condemns Middle East war, protest massacres
-
'Better than the Oscar': John Travolta gets surprise Cannes prize
-
Marsh muscle motors Lucknow to victory over Chennai
-
Judge declares mistrial in Weinstein case as jury fails to reach verdict
-
Eurovision finalists tune up as boycotting Spain digs in
-
Indonesia's first giant panda is set to charm the public
-
Cheer and tears as African refugee rap film 'Congo Boy' charms Cannes
-
Norwegian Ruud rolls into Italian Open final, Sinner set for Medvedev clash
-
Bolivia government says deal reached with protesting miners
-
Showdowns and spycraft on Trump-Xi summit sidelines
-
Smalley seizes PGA lead with Matsuyama making a charge
-
Acosta quickest in practice for Catalan MotoGP
-
Nuno wants VAR 'consistency' as West Ham fight to avoid relegation
-
Vingegaard powers to maiden Giro stage victory
-
Iran to hold pre-World Cup training camp in Turkey: media
-
US scraps deployment of 4,000 troops to Poland
-
Ukraine vows more strikes on Russia after attack on Kyiv kills 24
-
Bayern veteran Neuer signs one-year contract extension
-
Ukraine can down Russian drones en masse. But missiles are a problem
-
Israeli strikes wound dozens in Lebanon as talks in US enter second day
-
'Everybody wants Hearts to win', says Celtic's O'Neill ahead of title decider
-
Scheffler stumbles from share of lead at windy PGA
-
New deadly Ebola outbreak hits DR Congo
-
Farke calls for Leeds owners to match his ambition
-
Zverev pulls out of home event in Hamburg with back injury
-
Xi, Trump eke small wins from talks but no major deals: analysts
US abortion ruling threatens access to arthritis drug
When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.
"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.
Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.
"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.
Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.
It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.
"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.
The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.
Methotrexate stops cell division and is given in higher doses as a cancer drug.
It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.
Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.
- 'It's terrifying' -
Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.
A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.
She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.
Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.
A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."
Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.
Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.
In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.
CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."
Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.
"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.
Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.
"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.
E.Schubert--BTB